The rapidly growing health screening market addresses
early disease detection and prevention, improving outcomes and
reducing costs. This report explores emerging technologies like
Multi Cancer Detection Assays and AI (Artificial Intelligence) in
health screening.
BOSTON, July 10,
2024 /PRNewswire/ -- "According to the
latest BCC Research study, the demand for "Routine Health
Screening Market" is expected to grow from $59.7 billion in 2024 and is projected to reach
$82.9 billion by the end of 2029, at
a compound annual growth rate (CAGR) of 6.8% during the forecast
period of 2024 to 2029."
![BCC Research Logo BCC Research Logo](https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg)
The routine health screening market is experiencing robust
growth driven by increasing focus on preventive healthcare and
early disease detection. With a rising prevalence of
non-communicable diseases like diabetes and cardiovascular
disorders, coupled with a globally aging population, there is a
growing demand for proactive health management solutions.
Technological advancements, including AI-driven diagnostic tools,
are enhancing the accuracy and accessibility of screenings, making
them more widely available. The COVID-19 pandemic has further
underscored the importance of regular health check-ups, boosting
the market's significance. Integration into corporate wellness
programs and the trend towards personalized medicine are also
fueling market expansion, positioning routine health screenings as
crucial in proactive health management worldwide.
The following factors drive the global market for routine
health screening:
Growing Prevalence of Chronic Diseases: The rise in
chronic diseases such as diabetes, cardiovascular disease, and
cancer has significantly increased the need for regular health
check-ups. These screenings are essential for early detection and
timely intervention, necessary for effective treatment of chronic
diseases. Regular screening can prevent complications and improve
patient outcomes by identifying risk factors and monitoring health
status.
Growing Health Consciousness: Nowadays people know more
about their health than ever before. Regular health screening is
the way individuals can control their well development by
identifying potential health problems in the first few days. This
growing health awareness is supported by awareness campaigns,
health education measures, and preventive measures, all of which
contribute to increasing the tendency for routine health
checks.
Advancements in Screening Technology: The development of
technology has changed the methods of health examinations. Improved
diagnostic tools such as advanced imaging techniques such as MRI
and CT scans, genetic testing, and point-of-care devices have
improved the accuracy and efficiency of screenings. These
innovations enable earlier disease detection, more personalized
risk assessments, and customized treatment plans, making health
screenings more effective than ever before.
Request a Sample Copy of The global market for routine
health screening reports.
Report Synopsis
Report
Metrics
|
Details
|
Base year
considered
|
2023
|
Forecast Period
considered
|
2024-2029
|
Base year market
size
|
$56.6
billion
|
Market Size
Forecast
|
$82.9
billion
|
Growth rate
|
CAGR of 6.8% for the
forecast period of 2024-2029
|
Segment
Covered
|
Test Type, Sample Type,
Technology, and Region
|
Regions
covered
|
North America, Europe,
Asia-Pacific, and Rest of the World (RoW)
|
Countries
covered
|
U.S., Canada, Germany,
France, UK, Italy, Spain, China, India, Japan, Middle East, and
Africa
|
Key Market
Drivers
|
- Growing prevalence
of chronic diseases.
- Growing health
consciousness.
- Advancements in
screening technology.
|
Key Interesting Facts About the global market for routine
health screening:
- AI in Ophthalmology:
- Exceptional diagnostic capabilities in detecting retinal
conditions, glaucoma, and other eye diseases.
- State-of-the-art diagnostic systems built from fundus
images.
- Challenges in designing AI models with large
imaging datasets.
- Early detection of glaucoma through AI can lead to earlier
intervention.
- Potential to slow disease progression and reduce the risk of
significant vision loss.
- Multicancer Detection (MCD) Assays:
- Emerging development in routine health screening.
- Highlighted in the AACR Cancer Progress Report 2023.
- The study covers over 50 cancer types with a sample of more
than 5,000 individuals with suspected symptoms.
- Detected two-thirds of cancers.
- Accurately identified the origin site in 85% of cases.
- Modeling study based on cancer mortality data from England.
- Potential to reduce annual cancer-related deaths by 17% with
routine integration of MCDs.
The global market for routine health screening report
includes in-depth data and analysis addressing the following
important queries:
- What is the projected market size and growth rate of the
market?
The Global routine health screening market is projected to grow
from $56.6 billion in 2023 to
$82.9 billion in 2029, at a compound
annual growth rate (CAGR) of 6.8% during the forecast period.
- What are the key factors driving the growth of the market?
- Increase the prevalence of chronic diseases.
- Increase in health awareness.
- Advancements in technology.
- What segments are covered in the market?
This report segments the market based on type, technology, sample,
and region. The market is segmented based on the type into
Cholesterol Screening, Diabetes Screening, Blood Pressure Tests,
Cancer Screening, Prenatal screening, Vision and Hearing
Screenings, Bone Density Tests, Thyroid Profile Tests, Essential
Nutrients Tests, and Others. The market is segmented based on
technology into QPCR (Quantitative Polymerase Chain Reaction),
Q-FISH (Quantitative Fluorescence, in Situ Hybridization),
Immunoassays, Medical Imaging, STELA (Single Telomere Length
Analysis), and Others. The market is segmented into blood, urine,
saliva, imaging samples, and others based on application. Based on
region, the market is segmented into North America, Europe, Asia-Pacific, and the rest of the world.
- By Type, which segment will dominate the market by the end of
2029?
Diabetes will dominate the market by the end of 2029.
- Which region has the highest market share in the market?
North America holds the highest
share of the market.
Some of the Key Market Players Are:
- ARUP LABORATORIES
- CERBA HEALTHCARE
- EUROFINS SCIENTIFIC
- EXACT SCIENCE CORP.
- OPKO HEALTH INC.
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- NATERA INC.
- QUEST DIAGNOSTICS INC.
- SONIC HEALTHCARE LTD.
- SYNLAB AG
Browse More Related Reports:
Fetal Monitoring, Diagnostics, and Predictive
Tests: This report offers a detailed analysis of the
global market for fetal monitoring, diagnostics, and predictive
tests, providing both quantitative and qualitative data. It aims to
assist businesses in developing growth strategies, assessing the
market landscape, analyzing their current market positions, and
making informed decisions. The report includes historical data and
future projections on sales segmented by application, product type,
and end user. It covers several types of fetal monitoring,
diagnostics, and predictive tests, detailing their current and
historical market revenues. Additionally, the global market is
categorized by region, including North
America, Europe, and the
Rest of the World. To enhance understanding, the report profiles
the competitive landscape, highlighting key competitors and their
respective market shares.
AI in Diabetes Management: Global Market Outlook:
This report examines the global market for AI in diabetes
management, segmenting it by product type, technique, and
geographic region. It provides a comprehensive overview of market
trends and uses 2021 as the base year for estimating market data
and revenue projections for the forecast period from 2022 to 2027.
Market values are calculated based on the total revenue generated
by providers of AI-based diabetes management products. The scope of
this study encompasses AI in diabetes management care platforms and
associated services.
Directly Purchase a copy of the
report with BCC Research.
For further information or to make a purchase, please get in
touch with info@bccresearch.com.
About BCC Research
BCC Research provides objective, unbiased measurement and
assessment of market opportunities with detailed market research
reports. Our experienced industry analysts' goal is to help you
make informed business decisions, free of noise and hype.
Contact Us
Corporate HQ: 50 Milk St. Ste 16,
Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our
media page for access to our market research library.
Data and analysis extracted from this press release must be
accompanied by a statement identifying BCC Research LLC as the
source and publisher
Logo:
https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/advancements-in-health-screening-empowering-early-detection-and-prevention-302193380.html
SOURCE BCC Research LLC